This inventor holds 2 USPTO granted patents and 3 EPO patents. Top assignee: Nestec S.a.. Active years: 2007-2010.
Company Filing History:
Years Active: 2007-2010
Title: Michèle Delley: Innovator in Bifidobacteria Research
Introduction
Michèle Delley is a notable inventor based in Vauderens, Switzerland. He has made significant contributions to the field of microbiology, particularly in the study of bifidobacteria. With a total of 2 patents, his work has implications for both food and pharmaceutical industries.
Latest Patents
Delley's latest patents include "Serpin in bifidobacteria - A novel gene of Bifidobacteria and the polypeptides encoded thereby." This patent focuses on a gene belonging to the Serpin superfamily and its applications in producing bacterial Serpins. It also details vectors, host cells, and methods for producing bacterial Serpin polynucleotides and/or polypeptides. Another significant patent is "NCC2705—the genome of a bifidobacterium," which describes a novel microorganism and its genomic and plasmid sequences. This patent also outlines methods for producing polypeptides and detecting these nucleic acids or polypeptides. Additionally, it provides a data carrier comprising nucleotide sequences and/or polypeptide sequences of NCC2705, along with food and pharmaceutical compositions for preventing and/or treating diarrhea caused by rotaviruses and pathogenic bacteria.
Career Highlights
Throughout his career, Michèle Delley has worked with prominent companies such as Nestec S.A. and Société des Produits Nestlé S.A. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in the field.
Collaborations
Delley has collaborated with notable professionals in his field, including Fabrizio Arigoni and Mark Alan Schell. These collaborations have further enriched his research and development efforts.
Conclusion
In summary, Michèle Delley is a distinguished inventor whose work in bifidobacteria research has led to valuable patents and collaborations. His contributions continue to impact the food and pharmaceutical industries positively.